{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T19:42:55Z","timestamp":1770752575162,"version":"3.50.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"S2","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Syst Biol"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1186\/s12918-019-0698-7","type":"journal-article","created":{"date-parts":[[2019,4,5]],"date-time":"2019-04-05T11:02:37Z","timestamp":1554462157000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Anti-TNF- \u03b1treatment-related pathways and biomarkers revealed by transcriptome analysis in Chinese psoriasis patients"],"prefix":"10.1186","volume":"13","author":[{"given":"Lunfei","family":"Liu","sequence":"first","affiliation":[]},{"given":"Wenting","family":"Liu","sequence":"additional","affiliation":[]},{"given":"Yuxin","family":"Zheng","sequence":"additional","affiliation":[]},{"given":"Jisu","family":"Chen","sequence":"additional","affiliation":[]},{"given":"Jiong","family":"Zhou","sequence":"additional","affiliation":[]},{"given":"Huatuo","family":"Dai","sequence":"additional","affiliation":[]},{"given":"Suiqing","family":"Cai","sequence":"additional","affiliation":[]},{"given":"Jianjun","family":"Liu","sequence":"additional","affiliation":[]},{"given":"Min","family":"Zheng","sequence":"additional","affiliation":[]},{"given":"Yunqing","family":"Ren","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2019,4,5]]},"reference":[{"key":"698_CR1","doi-asserted-by":"publisher","first-page":"S50","DOI":"10.1038\/492S50a","volume":"492","author":"JM Crow","year":"2012","unstructured":"Crow JM. Psoriasis uncovered. Nature. 2012; 492:S50\u20131.","journal-title":"Nature"},{"key":"698_CR2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.det.2014.09.002","volume":"33","author":"J Kim","year":"2015","unstructured":"Kim J, Krueger JG. The immunopathogenesis of psoriasis. Dermatol Clin. 2015; 33:13\u201323.","journal-title":"Dermatol Clin"},{"key":"698_CR3","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/j.0906-6705.2004.00205.x","volume":"13","author":"AJ Schottelius","year":"2004","unstructured":"Schottelius AJ, Moldawer LL, Dinarello CA, Asadullah K, Sterry W, Edwards III CK. Biology of tumor necrosis factor-alpha- implications for psoriasis. Exp Dermatol. 2004; 13:193\u2013222.","journal-title":"Exp Dermatol"},{"key":"698_CR4","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.jaci.2009.08.046","volume":"124","author":"LC Zaba","year":"2009","unstructured":"Zaba LC, Suarez-Farinas M, Fuentes-Duculan J, Nograles KE, Guttman-Yassky E, Cardinale I, Lowes MA, Krueger JG. Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not immediate response TNF genes. J Allergy Clin Immunol. 2009; 124:1022\u201330.","journal-title":"J Allergy Clin Immunol"},{"key":"698_CR5","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1111\/jdv.12240","volume":"28","author":"A Balato","year":"2014","unstructured":"Balato A, Schiattarella M, Di Caprio R, Lembo S, Mattii M, Balato N, Ayala F. Effects of adalimumab therapy in adult subjects with moderate-to-severe psoriasis on Th17 pathway. J Eur Acad Dermatol Venereol. 2014; 28:1016\u201324.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"698_CR6","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1016\/j.jaci.2013.05.036","volume":"132","author":"PM Brunner","year":"2013","unstructured":"Brunner PM, Koszik F, Reininger B, Kalb ML, Bauer W, Stingl G. Infliximab induces downregulation of the IL-12\/IL-23 axis in 6-sulfo-lacnac (slan)+ dendritic cells and macrophages. J Allergy Clin Immunol. 2013; 132:1184\u201393.","journal-title":"J Allergy Clin Immunol"},{"key":"698_CR7","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/bjd.12937","volume":"171","author":"A Johnston","year":"2014","unstructured":"Johnston A, Guzman AM, Swindell WR, Wang F, Kang S, Gudjonsson JE. Early tissue responses in psoriasis to the antitumour necrosis factor-alpha biologic etanercept suggest reduced interleukin-17 receptor expression and signalling. Br J Dermatol. 2014; 171:97\u2013107.","journal-title":"Br J Dermatol"},{"key":"698_CR8","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/j.1365-2133.2012.10961.x","volume":"167","author":"F Wang","year":"2012","unstructured":"Wang F, Smith N, Maier L, Xia W, Hammerberg C, Chubb H, Chen C, Riblett M, Johnston A, Gudjonsson JE, et al. Etanercept suppresses regenerative hyperplasia in psoriasis by acutely downregulating epidermal expression of interleukin (IL)-19, IL-20 and IL-24. Br J Dermatol. 2012; 167:92\u2013102.","journal-title":"Br J Dermatol"},{"key":"698_CR9","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.ajpath.2013.04.021","volume":"183","author":"F Bose","year":"2013","unstructured":"Bose F, Petti L, Diani M, Moscheni C, Molteni S, Altomare A, Rossi RL, Talarico D, Fontana R, Russo V, et al. Inhibition of ccr7\/ccl19 axis in lesional skin is a critical event for clinical remission induced by tnf blockade in patients with psoriasis. Am J Pathol. 2013; 183:413\u201321.","journal-title":"Am J Pathol"},{"key":"698_CR10","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1111\/j.1365-2133.2010.10036.x","volume":"163","author":"C Johansen","year":"2010","unstructured":"Johansen C, Vinter H, Soegaard-Madsen L, Olsen LR, Steiniche T, Iversen L, Kragballe K. Preferential inhibition of the mRna expression of p38 mitogen-activated protein kinase regulated cytokines in psoriatic skin by anti-TNF \u03b1 therapy. Br J Dermatol. 2010; 163:1194\u2013204.","journal-title":"Br J Dermatol"},{"key":"698_CR11","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.clim.2011.01.015","volume":"139","author":"F Bose","year":"2011","unstructured":"Bose F, Raeli L, Garutti C, Frigerio E, Cozzi A, Crimi M, Caprioli F, Scavelli R, Altomare G, Geginat J, et al.Dual role of anti-TNF therapy: enhancement of TCR-mediated T cell activation in peripheral blood and inhibition of inflammation in target tissues. Clin Immunol. 2011; 139:164\u201376.","journal-title":"Clin Immunol"},{"key":"698_CR12","first-page":"988","volume":"15","author":"M Chow","year":"2016","unstructured":"Chow M, Lai K, Ahn R, Gupta R, Arron S, Liao W. Effect of adalimumab on gene expression profiles of psoriatic skin and blood. J Drugs Dermatol. 2016; 15:988\u201394.","journal-title":"J Drugs Dermatol"},{"key":"698_CR13","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1136\/ard.2006.063875","volume":"67","author":"AM Patterson","year":"2008","unstructured":"Patterson AM, Cartwright A, David G, Fitzgerald O, Bresnihan B, Ashton BA, Middleton J. Differential expression of syndecans and glypicans in chronically inflamed synovium. Ann Rheum Dis. 2008; 67:592\u2013601.","journal-title":"Ann Rheum Dis"},{"key":"698_CR14","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2340\/0001555577105109","volume":"77","author":"MM Seyger","year":"1997","unstructured":"Seyger MM, van den Born J, Schalkwijk J, van de Kerkhof PC, de Jong EM. Altered distribution of heparan sulfate proteoglycans in psoriasis. Acta Derm Venereol. 1997; 77:105\u20139.","journal-title":"Acta Derm Venereol"},{"key":"698_CR15","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1046\/j.1365-2133.1999.03205.x","volume":"141","author":"M Bhushan","year":"1999","unstructured":"Bhushan M, McLaughlin B, Weiss JB, Griffiths CE. Levels of endothelial cell stimulating angiogenesis factor and vascular endothelial growth factor are elevated in psoriasis. Br J Dermatol. 1999; 141:1054\u201360.","journal-title":"Br J Dermatol"},{"key":"698_CR16","doi-asserted-by":"publisher","first-page":"21264","DOI":"10.1073\/pnas.0907550106","volume":"106","author":"HB Schonthaler","year":"2009","unstructured":"Schonthaler HB, Huggenberger R, Wculek SK, Detmar M, Wagner EF. Systemic anti-VEGF treatment strongly reduces skin inflammation in a mouse model of psoriasis. Proc Natl Acad Sci. 2009; 106:21264\u20139.","journal-title":"Proc Natl Acad Sci"},{"key":"698_CR17","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1177\/0300060515593229","volume":"44","author":"A Campanati","year":"2016","unstructured":"Campanati A, Orciani M, Ganzetti G, Consales V, Di Primio R, Offidani A. The effect of etanercept on vascular endothelial growth factor production by cutaneous mesenchymal stem cells from patients with psoriasis. J Int Med Res. 2016; 44:6\u20139.","journal-title":"J Int Med Res"},{"key":"698_CR18","doi-asserted-by":"publisher","first-page":"2721","DOI":"10.4049\/jimmunol.175.4.2721","volume":"175","author":"AB Gottlieb","year":"2005","unstructured":"Gottlieb AB, Chamian F, Masud S, Cardinale I, Abello MV, Lowes MA, Chen F, Magliocco M, Krueger JG. TNF inhibition rapidly down-regulates multiple proinflammatory pathways in psoriasis plaques. J Immunol. 2005; 175:2721\u20139.","journal-title":"J Immunol"},{"key":"698_CR19","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1111\/j.1574-695X.2007.00231.x","volume":"49","author":"AA Awomoyi","year":"2007","unstructured":"Awomoyi AA. The human solute carrier family 11 member 1 protein (SLC11A1): linking infections, autoimmunity and cancer?FEMS Immunol Med Microbiol. 2007; 49:324\u20139.","journal-title":"FEMS Immunol Med Microbiol"},{"key":"698_CR20","doi-asserted-by":"publisher","first-page":"e204","DOI":"10.1093\/nar\/gkq871","volume":"38","author":"W Shi","year":"2010","unstructured":"Shi W, Oshlack A, Smyth GK. Optimizing the noise versus bias trade-off for illumina whole genome expression beadchips. Nucleic Acids Res. 2010; 38:e204.","journal-title":"Nucleic Acids Res"},{"key":"698_CR21","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015; 43:e47.","journal-title":"Nucleic Acids Res"},{"key":"698_CR22","doi-asserted-by":"publisher","first-page":"Article 3","DOI":"10.2202\/1544-6115.1027","volume":"3","author":"GK Smyth","year":"2004","unstructured":"Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol. 2004; 3:Article 3.","journal-title":"Stat Appl Genet Mol Biol"},{"key":"698_CR23","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S. WGCNA, an R package for weighted correlation network analysis. BMC Bioinformatics. 2008; 9:559.","journal-title":"BMC Bioinformatics"},{"key":"698_CR24","unstructured":"Alexa A, Rahnenfuhrer J. Gene set enrichment analysis with topGo. 2018. ( www.bioconductor.org )."}],"container-title":["BMC Systems Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12918-019-0698-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12918-019-0698-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12918-019-0698-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T12:18:45Z","timestamp":1694780325000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcsystbiol.biomedcentral.com\/articles\/10.1186\/s12918-019-0698-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":24,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["698"],"URL":"https:\/\/doi.org\/10.1186\/s12918-019-0698-7","relation":{},"ISSN":["1752-0509"],"issn-type":[{"value":"1752-0509","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"5 April 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"29"}}